Diffuse, non-traumatic, non-aneurysmal subarachnoid haemorrhage during bevacizumab treatment of high grade glioma: case report and review of the literature

Background: Bevacizumab is a monoclonal antibody against vascular endothelial growth factor approved by the United States Food and Drug Administration for the treatment of various cancers including refractory high grade glioma. There are case reports of subarachnoid haemorrhage (SAH) during bevacizu...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Arosha S. Dissanayake, MBBS, Hari H. Ramakonar, MBBS, Christopher R.P. Lind, MBBS, FRACS
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2015-06-01
coleção:	Interdisciplinary Neurosurgery
Assuntos:	Bevacizumab High grade glioma Subarachnoid haemorrhage
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2214751915000031
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!